Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
1(9%)
Results Posted
0%(0 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_4
1
9%
Ph phase_2
1
9%
Ph not_applicable
9
82%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Terminated(2)

Detailed Status

Completed8
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (9.1%)
Phase 41 (9.1%)
N/A9 (81.8%)

Trials by Status

recruiting19%
terminated218%
completed873%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11